Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Venook

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|September 8, 2010
Nonadherence to imatinib during an economic downturnRobin K Kelley, Alan P Venook
Oncology (Williston Park, N.Y.)|May 2, 2012
Metastatic colorectal cancer: a curable diseaseKatherine Van Loon, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Shedding old paradigms: developing viruses to treat cancerEmily K Bergsland, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Sorafenib in hepatocellular carcinoma: separating the hype from the hopeRobin K Kelley, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2026
Ending the Controversy Around Pretreatment Dihydropyrimidine Dehydrogenase (DPD/<i>DPYD</i>) Testing Heightens the Controversy Over Appropriate Fluoropyrimidine DosingDaniel L Hertz, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicitiesKatherine Van Loon, Alan P Venook
Clinical Colorectal Cancer|August 24, 2011
Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?Robin K Kelley, Alan P Venook
Current Opinion in Oncology|May 4, 2011
Adjuvant treatment of colon cancer: what is next?Katherine Van Loon, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Trying to Understand Differing Results of FIRE-3 and 80405: Does the First Treatment Matter More Than Others?Bert H O'Neil, Alan P Venook
Gastrointestinal Cancer Research : GCR|March 5, 2009
Responding to the rising incidence of hepatocellular carcinoma with targeted therapySu-Pin Choo, Alan P Venook
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|September 8, 2010
Nonadherence to imatinib during an economic downturnRobin K Kelley, Alan P Venook
Oncology (Williston Park, N.Y.)|May 2, 2012
Metastatic colorectal cancer: a curable diseaseKatherine Van Loon, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Shedding old paradigms: developing viruses to treat cancerEmily K Bergsland, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Sorafenib in hepatocellular carcinoma: separating the hype from the hopeRobin K Kelley, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2026
Ending the Controversy Around Pretreatment Dihydropyrimidine Dehydrogenase (DPD/<i>DPYD</i>) Testing Heightens the Controversy Over Appropriate Fluoropyrimidine DosingDaniel L Hertz, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicitiesKatherine Van Loon, Alan P Venook
Clinical Colorectal Cancer|August 24, 2011
Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?Robin K Kelley, Alan P Venook
Current Opinion in Oncology|May 4, 2011
Adjuvant treatment of colon cancer: what is next?Katherine Van Loon, Alan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Trying to Understand Differing Results of FIRE-3 and 80405: Does the First Treatment Matter More Than Others?Bert H O'Neil, Alan P Venook
Gastrointestinal Cancer Research : GCR|March 5, 2009
Responding to the rising incidence of hepatocellular carcinoma with targeted therapySu-Pin Choo, Alan P Venook
Pageof 25